PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
09-Sep-2024 CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress CureVac
09-Sep-2024 Moderna’s Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada AccessWire
09-Sep-2024 Meso Numismatics Announces Cellgenic’s Sponsorship of Three Prominent Regenerative Medicine Events in Peru This September Newswire
09-Sep-2024 Interactive Strength Inc. (Nasdaq: TRNR) to Present at the H.C. Wainwright 26th Annual Global Investment Conference and Meet Institutional Investors in New York from September 9th to 11th AccessWire
09-Sep-2024 Sale of Gentronix to Danish group provides an exit for investor Mercia Ventures Mercia Ventures
09-Sep-2024 Provepharm launches Blumyne™ surgical dye in UK Andrew Lloyd Associates
09-Sep-2024 Animal Feed Enzymes Market Growth, Trends, and Forecast: Key Insights and Projections Till 2032 Ameco Research
09-Sep-2024 Nurse Call Systems Market is Likely to Grasp the CAGR of 9.5% During the Forecast Period of 2024 to 2032 Acumen Research and Consulting
09-Sep-2024 DiogenX welcomes Eleanor L. Ramos as independent member of its Board of Directors Andrew Lloyd Associates
09-Sep-2024 VIVES IUF Fund raises additional €5M capital from Luxembourg Future Fund 2 Andrew Lloyd Associates
09-Sep-2024 Sports Nutrition Market Projected Growth from USD 53.41 Billion in 2023 to USD 76.8 Billion by 2030, with a CAGR of 5.6 Percentage MAXIMIZE MARKET RESEARCH PVT. LTD.
09-Sep-2024 Hemogenyx Pharmaceuticals PLC - FLT3 Assay Ready for Phase I Trials at MD Anderson AccessWire
06-Sep-2024 Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements AccessWire
06-Sep-2024 Tenon(R) Medical Announces First Peer Reviewed Publication of the MAINSAIL(TM) Study Analyzing the First 33 Consecutive Patients from an IRB Approved, Prospective, Multi-Centered, Post-Market Clinical Investigation Utilizing the Catamaran(R) SI Joint Fusion System AccessWire
06-Sep-2024 AI/ML Innovations Inc. Provides Status Update AccessWire
06-Sep-2024 Xinnate presents TCP-25 data at international dermatology congress Xinnate AB
06-Sep-2024 PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies PureTech Health plc
06-Sep-2024 Asgard Therapeutics’ study published in Science showing proof-of-concept and strong anti-tumor responses via in vivo cell reprogramming with lead program AT-108 Asgard Therapeutics
06-Sep-2024 Realheart to Present Positive Results From Two Preclinical Studies Evaluating Treatment Safety of Its Total Artificial Heart at ISMCS 2024 Scandinavian Real Heart AB
06-Sep-2024 In a fixed dose study, once weekly insulin efsitora alfa leads to HbA1C reduction similar to daily insulin Eli Lilly and Company